PMC:7441777 / 432-773
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T3 | 178-181 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T4 | 192-195 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T5 | 235-238 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T5 | 41-49 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T6 | 168-176 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T7 | 224-232 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T5 | 9-13 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T6 | 89-93 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T7 | 107-111 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T8 | 149-157 | Chemical | denotes | solution | http://purl.obolibrary.org/obo/CHEBI_75958 |
| T9 | 287-301 | Chemical | denotes | antiviral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
| T10 | 287-296 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T11 | 297-301 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 235-250 | http://purl.obolibrary.org/obo/GO_0039703 | denotes | RNA replication |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 44 | 208-212 | Gene | denotes | RdRp | Gene:43740578 |
| 56 | 224-234 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 77 | 41-49 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 78 | 168-176 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9 | 51-177 | Sentence | denotes | Due to the time taking process of new drug development, drug repurposing might be the only viable solution to tackle COVID-19. |
| T10 | 178-309 | Sentence | denotes | RNA‐dependent RNA polymerase (RdRp) catalyzes SARS-CoV-2 RNA replication and hence, is an obvious target for antiviral drug design. |